Survive the broken arm! In the cold winter, another star drug was forced to terminate the clinical trial enterprise, and how did the capital start again jqknews Post date May 15, 2022 — 21:44 Post Lock Read More Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Kanghong Pharmaceutical's new indication of Conbercept ophthalmic injection approved_Shenzhen Hotline Post date May 7, 2022 — 20:07 Post Lock Read More Kanghong Pharmaceutical achieves a net profit of 421 million yuan in 2021, and the business performance of proprietary Chinese medicines and biological products is outstanding Post date May 4, 2022 — 23:29 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, an increase of 27.22% year-on-year Post date April 30, 2022 — 16:20 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, a year-on-year increase of 27.22% – yqqlm Post date April 30, 2022 — 16:18 Post Lock Read More Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains Post date May 10, 2022 — 10:07 Post Lock Read More Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Kanghong Pharmaceutical's new indication of Conbercept ophthalmic injection approved_Shenzhen Hotline Post date May 7, 2022 — 20:07 Post Lock Read More Kanghong Pharmaceutical achieves a net profit of 421 million yuan in 2021, and the business performance of proprietary Chinese medicines and biological products is outstanding Post date May 4, 2022 — 23:29 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, an increase of 27.22% year-on-year Post date April 30, 2022 — 16:20 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, a year-on-year increase of 27.22% – yqqlm Post date April 30, 2022 — 16:18 Post Lock Read More Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Kanghong Pharmaceutical's new indication of Conbercept ophthalmic injection approved_Shenzhen Hotline Post date May 7, 2022 — 20:07 Post Lock Read More Kanghong Pharmaceutical achieves a net profit of 421 million yuan in 2021, and the business performance of proprietary Chinese medicines and biological products is outstanding Post date May 4, 2022 — 23:29 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, an increase of 27.22% year-on-year Post date April 30, 2022 — 16:20 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, a year-on-year increase of 27.22% – yqqlm Post date April 30, 2022 — 16:18 Post Lock Read More Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Kanghong Pharmaceutical's new indication of Conbercept ophthalmic injection approved_Shenzhen Hotline Post date May 7, 2022 — 20:07 Post Lock Read More Kanghong Pharmaceutical achieves a net profit of 421 million yuan in 2021, and the business performance of proprietary Chinese medicines and biological products is outstanding Post date May 4, 2022 — 23:29 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, an increase of 27.22% year-on-year Post date April 30, 2022 — 16:20 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, a year-on-year increase of 27.22% – yqqlm Post date April 30, 2022 — 16:18 Post Lock Read More Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Kanghong Pharmaceutical achieves a net profit of 421 million yuan in 2021, and the business performance of proprietary Chinese medicines and biological products is outstanding Post date May 4, 2022 — 23:29 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, an increase of 27.22% year-on-year Post date April 30, 2022 — 16:20 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, a year-on-year increase of 27.22% – yqqlm Post date April 30, 2022 — 16:18 Post Lock Read More Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, an increase of 27.22% year-on-year Post date April 30, 2022 — 16:20 Post Lock Read More Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, a year-on-year increase of 27.22% – yqqlm Post date April 30, 2022 — 16:18 Post Lock Read More Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Kanghong Pharmaceutical: Net profit in the first quarter of 2022 is about 297 million yuan, a year-on-year increase of 27.22% – yqqlm Post date April 30, 2022 — 16:18 Post Lock Read More Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Kanghong Pharmaceutical: Net profit in 2021 is about 421 million yuan Post date April 30, 2022 — 16:15 Post Lock Read More Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Kanghong Pharmaceutical: Received the Drug Clinical Trial Approval Notice for Obeticholic Acid Tablets Post date April 24, 2022 — 22:44 Post Lock Read More Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Announcement of Chengdu Kanghong Pharmaceutical Group Co., Ltd. on the use of its own funds to purchase wealth management products Post date April 16, 2022 — 07:15 Post Lock Read More The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
The utilization rate of traditional Chinese medicine among those with positive infection in Shanghai exceeds 98%. Post date April 6, 2022 — 19:31 Post Lock Read More There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
There are many well-known companies and well-known varieties of 77 drug applications withdrawn from the Internet Post date April 3, 2022 — 07:41 Post Lock Read More
Caishen.CoCaishen.Co